Conduction Abnormalities after Transcatheter Aortic Valve Implantation: Incidence, Impact and Management Using CT Data Interpretation-Reference-Cited by-同舟云学术

Conduction Abnormalities after Transcatheter Aortic Valve Implantation: Incidence, Impact and Management Using CT Data Interpretation

Published:2024-08-13 Issue: Volume:19 Page:
ISSN:1756-1485
Container-title:Interventional Cardiology: Reviews, Research, Resources
language:en
Short-container-title:Interv Cardiol

Author:

Nuis Rutger-Jan¹^ORCID,van den Dorpel Mark¹^ORCID,Adrichem Rik¹^ORCID,Daemen Joost¹^ORCID,Van Mieghem Nicolas¹^ORCID

Affiliation:

1. Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands

Abstract

The demonstrated safety and effectiveness of transcatheter aortic valve implantation (TAVI) among low surgical risk patients opened the road to its application in younger low-risk patients. However, the occurrence of conduction abnormalities and need for permanent pacemaker implantation remains a frequent problem associated with adverse outcomes. The clinical implications may become greater when TAVI shifts towards younger populations, highlighting the need for comprehensive strategies to address this issue. Beyond currently available clinical and electrocardiographic predictors, patient-specific anatomical assessment of the aortic root using multi-sliced CT (MSCT) imaging can refine risk stratification. Moreover, leveraging MSCT data for computational 3D simulations to predict device-anatomy interactions may help guide procedural strategy to mitigate conduction abnormalities. The aims of this review are to summarise the incidence and clinical impact of new left bundle branch block and permanent pacemaker implantation post-TAVI using contemporary transcatheter heart valves; and highlight the value of MSCT data interpretation to improve the management of this complication.

Publisher

Radcliffe Media Media Ltd

Reference57 articles.

1. Writing Committee, Otto CM, Nishimura RA, et al. ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. J Am Coll Cardiol 2020;77:e25–e197.https://doi.org/10.1016/j.jacc.2020.11.018; PMID: 33342586

2. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2021;60:727–800. https://doi.org/10.1093/ejcts/ezab389; PMID: 34453161.

3. Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the US Society of Thoracic Surgeons/American College of Cardiology TVT Registry. JACC Cardiovasc Interv 2016;9:2189–99. https://doi.org/10.1016/j.jcin.2016.07.026; PMID: 27832844.

4. Houthuizen P, van der Boon RM, Urena M, et al. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention 2014;9:1142–50. https://doi.org/10.4244/EIJV9I10A194; PMID: 24273252.

5. Urena M, Mok M, Serra V, et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol 2012;60:1743–52. https://doi.org/10.1016/j.jacc.2012.07.035; PMID: 23040577.